Dr Eugenii Rabiner MBBCh
Reader in Molecular Neuroimaging
- Imaging sciences
I use molecular and functional imaging to investigate human neurochemistry, in particular the application of PET and MRI to optimise early phase drug development. My current research projects include the development of imaging techniques to quantify neuroinflammation and to extend the detection of endogenous neurotransmitter release beyond that of dopamine. I am also the Executive Vice President, Head of Translational Applications at Invicro.
Please see my Research Staff Profile for more detail
Find out more about my research:
- Colasanti et al. 2012, Endogenous opioid release in the human brain reward system induced by acute amphetamine administration, Biological Psychiatry
- Rabiner et al. 2001. Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low. American Journal of Psychiatry
- Rabiner et al., 2011. Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Molecular Psychiatry.
- Professor Roger Gunn, Invicro
- Professor Gitte Moos-Knudsen, University of Copenhagen
- Professor Richard Carson, Yale University
- Professor Mark Slifstein, SUNY Stonybrook